New cocktail of drugs shows promise against bone marrow cancer
NCT ID NCT05392946
First seen Oct 31, 2025 · Last updated Apr 29, 2026 · Updated 24 times
Summary
This study tests a new drug, iberdomide, combined with three other drugs (daratumumab, bortezomib, and dexamethasone) in people newly diagnosed with multiple myeloma, a type of blood cancer. The goal is to find the best dose of iberdomide and see how well the combination works at killing cancer cells. About 49 adults will take part, and the treatment aims to control the disease rather than cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMA CELL MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.